Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Sk, Libutti"'
Publikováno v:
Journal of Cancer, Vol 3, Iss 1, Pp 207-216 (2012)
Background: Heterogeneity of surgical care exists among surgeons regarding the conduct of thyroidectomy and parathyroidectomy.Aim: To identify the current patterns of technical conduct of operation amongst surgeons performing thyroidectomy or parathy
Externí odkaz:
https://doaj.org/article/5c51e2feb6954f9bbf24ab16e44cf91e
Autor:
Andrew Feldman, Tamarkin L, Gf, Paciotti, Bw, Simpson, Wm, Linehan, Jc, Yang, We, Fogler, Em, Turner, Hr, Alexander, Sk, Libutti
Publikováno v:
Europe PubMed Central
Clear cell renal carcinoma (CCRC) is a highly angiogenic tumor known to secrete vascular endothelial cell growth factor (VEGF). Endostatin is an endogenous antiangiogenic agent with antitumor activity in mice. The purpose of this study was to evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::19ad7d8b8680d750435eadee9b76cc31
https://pubmed.ncbi.nlm.nih.gov/11156212
https://pubmed.ncbi.nlm.nih.gov/11156212
Autor:
Michael Gnant, Ac, Berger, Huang J, Puhlmann M, Pc, Wu, Mj, Merino, Dl, Bartlett, Hr, Alexander Jr, Sk, Libutti
Publikováno v:
Europe PubMed Central
Tumor necrosis factor alpha (TNF-alpha) is a proinflammatory cytokine with potent experimental antitumor activity. Its clinical use in cancer treatment is severely limited by its considerable toxicity after systemic administration, and it is currentl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b0b11c8db7e4643ba80f254f028eeb30
http://europepmc.org/abstract/med/10493523
http://europepmc.org/abstract/med/10493523
Autor:
Te, Lans, Dl, Bartlett, Sk, Libutti, Michael Gnant, Dj, Liewehr, Dj, Venzon, Em, Turner, Hr, Alexander
Publikováno v:
Europe PubMed Central
Isolated limb or liver perfusion with tumor necrosis factor (TNF) and melphalan results in regression of advanced cancers in the majority of treated patients. However, the contribution of TNF to the efficacy of isolation perfusion with melphalan has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::397dff173d83039fb46cbf56a1da26c3
http://europepmc.org/abstract/med/11309322
http://europepmc.org/abstract/med/11309322
Autor:
Pc, Wu, Hr, Alexander, Huang J, Hwu P, Michael Gnant, Ac, Berger, Turner E, Wilson O, Sk, Libutti
Publikováno v:
Europe PubMed Central
Tumor necrosis factor (TNF)-alpha is a potent anticancer agent that seems to selectively target tumor-associated vasculature resulting in hemorrhagic necrosis of tumors without injury to surrounding tissues. The major limitation in the clinical use o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6cdd22296b172056613c938f864c8266
http://europepmc.org/abstract/med/9892208
http://europepmc.org/abstract/med/9892208
Publikováno v:
Europe PubMed Central
Gene therapy represents a possible alternative to the chronic delivery of recombinant antiangiogenic proteins to cancer patients. Inducing normal host tissues to produce high circulating levels of these proteins may be more effective than targeting a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::fde4687ad8b3512fe6eaab9968069a13
http://europepmc.org/abstract/med/10749112
http://europepmc.org/abstract/med/10749112
Autor:
Pal, Lal Chand1,2, Prateeksha1, Singh, Brahma Nand1, Pande, Veena2, Rao, Chandana Venkateswara1
Publikováno v:
Nutrition & Cancer. 2022, Vol. 74 Issue 3, p1106-1121. 16p. 3 Color Photographs, 4 Charts, 2 Graphs.
Publikováno v:
Clinical Laboratory; 2024, Vol. 70 Issue 1, p1-10, 10p
Publikováno v:
Frontiers in Endocrinology; 9/15/2022, Vol. 13, p1-9, 9p
Autor:
Roženková, Klára1,2, Güemes, Maria2,3, Shah, Pratik2,3, Hussain, Khalid2,3 khalid.hussain@ucl.ac.uk
Publikováno v:
Journal of Clinical Research in Pediatric Endocrinology. Jun2015, Vol. 7 Issue 2, p86-97. 12p.